WEFIXANYFONE LTD
Company number 13828346 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
WEFIXANYFONE LTD - Analysis Report
Company Number: 13828346
Analysis Date: 2025-07-29 18:01 UTC
Financial Health Assessment for WEFIXANYFONE LTD
1. Financial Health Score: D
Explanation:
The company exhibits some concerning signs in its financial statements, notably negative net assets and shareholders' funds, indicating financial distress. While current assets slightly exceed current liabilities, overall the company holds net liabilities, which suggests a fragile financial position. The score "D" reflects a need for prompt management focus to restore financial stability.
2. Key Vital Signs
| Vital Sign | Value (2024) | Interpretation |
|---|---|---|
| Current Assets | £15,435 | Indicates available liquid resources like cash and stock. |
| Current Liabilities | £18,127 | Debts due within one year, slightly exceeding current assets. |
| Net Current Assets | £-2,692 | Negative working capital — a symptom of liquidity strain. |
| Net Assets (Equity) | £-2,692 | Negative shareholders’ funds indicate the company owes more than it owns. |
| Shareholders’ Funds | £-2,692 | Reflects accumulated losses; shareholder value is currently negative. |
| Number of Employees | 0 (2024) | No employees this year, down from 2 last year, signaling possible operational contraction. |
Interpretation of Vital Signs:
The company’s negative net assets and shareholders' funds are critical "symptoms of distress." Negative working capital highlights potential short-term liquidity problems, meaning the company may struggle to meet immediate obligations without additional funding or asset sales. The absence of employees suggests minimal operational activity, which could impact revenue generation.
3. Diagnosis
The financial profile of WEFIXANYFONE LTD resembles a patient with weakened cardiovascular health: the core assets are insufficient to cover liabilities, indicating financial vulnerability. The company has been operating at a deficit for at least two years, leading to erosion of shareholder equity—the equivalent of dwindling vital reserves in a patient.
The negative net assets imply that the business is effectively "in the red," with liabilities outweighing assets. This situation may limit the company's ability to secure credit or investment, akin to a patient with compromised immunity being vulnerable to external shocks.
The slight improvement from a -£7,446 net asset position in 2023 to -£2,692 in 2024 shows some recovery but not enough to declare financial wellness. The decrease in liabilities or increase in assets seems minimal and insufficient to restore full health.
4. Recommendations
To improve financial wellness, the company should consider the following interventions:
Enhance Liquidity Management:
- Focus on accelerating cash inflows and managing payables to improve working capital. Consider negotiating better payment terms with suppliers or customers.
- Establish a cash flow forecast to anticipate and manage short-term liquidity needs proactively.
Capital Injection or Debt Restructuring:
- Seek additional equity investment to strengthen shareholder funds or refinance existing debt to reduce interest burdens and improve solvency.
- Consider approaching existing shareholders or new investors for fresh capital.
Operational Review:
- Reassess business operations and cost structure given the employee reduction to zero, ensuring the company is positioned to generate sufficient revenue.
- Explore strategic partnerships or cost-effective outsourcing to maintain service continuity without heavy fixed costs.
Regular Financial Monitoring:
- Implement monthly financial reviews to detect early warning signs of distress and respond rapidly.
- Engage financial advisory support if necessary to navigate turnaround strategies.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.